Where	O
applicable	O
,	O
immunohistochemistry	O
and	O
in	O
situ	O
hybridization	O
teats	O
were	O
.	O
developed	O
and	O
the	O
performance	O
characteristics	O
determined	O
by	O
the	O
.	O
have	O
not	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
US	O
Food	O
and	O
Drug	O
Administration	O
.	O
and	O
the	O
results	O
should	O
be	O
correlated	O
with	O
other	O
clinical	O
and	O
laboratory	O
.	O
data	O
.	O
